Follicular lymphoma with leukemic phase at diagnosis: An aggressive disease. Report of seven cases and review of the literature

od Beltran, Brady E., Castillo, Jorge J., Quiñones, Pilar, Morales, Domingo, Alva, Jose C., Miranda, Roberto N., Shah, Bijal D., Sotomayor, Eduardo M.
Izdano 2013

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas

od Wang, Michelle Y., Li, Tao, Ren, Yuan, Shah, Bijal D., Lwin, Tint, Gao, Jing, Shain, Kenneth H., Zhang, Wei, Zhao, Xiaohong, Tao, Jianguo
izdano v Blood Cancer J (2021)

Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia

od Sweet, Kendra, Komrokji, Rami, Padron, Eric, Cubitt, Christopher L., Turner, Joel G., Zhou, Junmin, List, Alan F., Sallman, David A., Dawson, Jana L., Sullivan, Daniel M., Chavez, Julio, Shah, Bijal D., Lancet, Jeffrey E.
izdano v Clin Cancer Res (2019)

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

od Sim, Austin J., Jain, Michael D., Figura, Nicholas B., Chavez, Julio C., Shah, Bijal D., Khimani, Farhad, Lazaryan, Aleksandr, Krivenko, Gabriel, Davila, Marco L., Liu, Hien D., Falchook, Aaron D., Dahiya, Saurabh, Rapoport, Aaron P., Kim, Sungjune, Locke, Frederick L., Robinson, Timothy J.
izdano v Int J Radiat Oncol Biol Phys (2019)

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

od Dean, Erin A., Mhaskar, Rahul S., Lu, Hong, Mousa, Mina S., Krivenko, Gabriel S., Lazaryan, Aleksandr, Bachmeier, Christina A., Chavez, Julio C., Nishihori, Taiga, Davila, Marco L., Khimani, Farhad, Liu, Hien D., Pinilla-Ibarz, Javier, Shah, Bijal D., Jain, Michael D., Balagurunathan, Yoganand, Locke, Frederick L.
izdano v Blood Adv (2020)

Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma

od Zhao, Xiaohong, Wang, Michelle Y., Jiang, Huijuan, Lwin, Tint, Park, Paul M., Gao, Jing, Meads, Mark B., Ren, Yuan, Li, Tao, Sun, Jiao, Fahmi, Naima Ahmed, Singh, Satishkumar, Sehgal, Lalit, Wang, Xuefeng, Silva, Ariosto S., Sotomayor, Eduardo M., Shain, Kenneth H., Cleveland, John L., Wang, Michael, Zhang, Wei, Qi, Jun, Shah, Bijal D., Tao, Jianguo
izdano v Cell Rep (2021)

PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

od Ren, Yuan, Bi, Chengfeng, Zhao, Xiaohong, Lwin, Tint, Wang, Cheng, Yuan, Ji, Silva, Ariosto S., Shah, Bijal D., Fang, Bin, Li, Tao, Koomen, John M., Jiang, Huijuan, Chavez, Julio C., Pham, Lan V., Sudalagunta, Praneeth R., Wan, Lixin, Wang, Xuefeng, Dalton, William S., Moscinski, Lynn C., Shain, Kenneth H., Vose, Julie, Cleveland, John L., Sotomayor, Eduardo M., Fu, Kai, Tao, Jianguo
izdano v J Clin Invest (2018)

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

od Hoogland, Aasha I., Jayani, Reena V., Collier, Aaron, Irizarry‐Arroyo, Nathaly, Rodriguez, Yvelise, Jain, Michael D., Booth‐Jones, Margaret, Hyland, Kelly A., James, Brian W., Barata, Anna, Bachmeier, Christina A., Chavez, Julio C., Khimani, Farhad, Krivenko, Gabriel S., Lazaryan, Aleksandr, Liu, Hien D., Nishihori, Taiga, Pinilla‐Ibarz, Javier, Shah, Bijal D., Abidi, Muneer, Locke, Frederick L., Jim, Heather S. L.
izdano v Cancer Med (2021)

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

od Logue, Jennifer M., Zucchetti, Elisa, Bachmeier, Christina A., Krivenko, Gabriel S., Larson, Victoria, Ninh, Daniel, Grillo, Giovanni, Cao, Biwei, Kim, Jongphil, Chavez, Julio C., Baluch, Aliyah, Khimani, Farhad, Lazaryan, Aleksandr, Nishihori, Taiga, Liu, Hien D., Pinilla-Ibarz, Javier, Shah, Bijal D., Faramand, Rawan, Coghill, Anna E., Davila, Marco L., Dholaria, Bhagirathbhai R., Jain, Michael D., Locke, Frederick L.
izdano v Haematologica (2020)

Cardiovascular Events Among Adults Treated with Chimeric Antigen Receptor T-Cells (CAR-T)

od Alvi, Raza M., Frigault, Matthew J., Fradley, Michael G., Jain, Michael D., Mahmood, Syed S., Awadalla, Magid, Lee, Dae Hyun, Zlotoff, Daniel A., Zhang, Lili, Drobni, Zsofia D., Hassan, Malek Z.O., Bassily, Emmanuel, Rhea, Isaac, Ismail-Khan, Roohi, Mulligan, Connor P., Banerji, Dahlia, Lazaryan, Aleksandr, Shah, Bijal D., Rokicki, Adam, Raje, Noopur, Chavez, Julio. C., Abramson, Jeremy, Locke, Frederick L., Neilan, Tomas. G.
izdano v J Am Coll Cardiol (2019)

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models

od Zhao, Xiaohong, Ren, Yuan, Lawlor, Matthew, Shah, Bijal D., Park, Paul M.C., Lwin, Tint, Wang, Xuefeng, Liu, Kenian, Wang, Michelle, Gao, Jing, Li, Tao, Xu, Mousheng, Silva, Ariosto S., Lee, Kaplan, Zhang, Tinghu, Koomen, John M., Jiang, Huijuan, Sudalagunta, Praneeth R., Meads, Mark B., Cheng, Fengdong, Bi, Chengfeng, Fu, Kai, Fan, Huitao, Dalton, William S., Moscinski, Lynn C., Shain, Kenneth H., Sotomayor, Eduardo M., Wang, Gang Greg, Gray, Nathanael S., Cleveland, John L., Qi, Jun, Tao, Jianguo
izdano v Cancer Cell (2019)